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Abstract
Background: Regionally partitioned health indicator values are commonly presented in choropleth maps.
Policymakers and health authorities use them among others for health reporting, demand planning and quality
assessment. Quite often there are concerns whether the health situation in certain areas can be considered
different or equivalent to a reference value.
Results: Highlighting statistically significant areas enables the statement that these areas differ from the reference
value. However, this approach does not allow conclusions which areas are sufficiently close to the reference value,
although these are crucial for health policy making as well. In order to overcome this weakness a combined
integration of statistical difference and equivalence tests into choropleth maps is suggested and the approach is
exemplified with health data of Austrian newborns.
Conclusions: The suggested method will improve the interpretability of choropleth maps for policymakers and
health authorities.
Background
A choropleth map consists of coloured or patterned
areas which represent different values or categories of a
quantitative attribute. Displaying health information
data in choropleth maps has become common practice
in spatial epidemiology.
Statistically significant deviations of the depicted
values from a reference value are often highlighted in
such maps. Their results, however, may lead to
unwanted concerns and bewilderment in certain signifi-
cantly worse regions. Inhabitants of those regions may
put political pressure on local authorities and govern-
mental agencies. However, in spatial units with many
observed events, even tiny and irrelevant effects may
show statistical significance. On the other hand, statisti-
cal difference tests usually have little statistical power
for areas exhibiting few events which could intuitively
lead to the false impression that areas with non-signifi-
cant test results are close to the reference value.
Equivalence tests can provide useful information in
addition to difference tests as the former require the
specification of a conclusively substantiated equivalence
range. We suggest the combined use of both difference
and equivalence tests in spatial maps. We exemplify that
this combined approach provides more insight into spa-
tial conditions than sole difference tests. We think that
it can considerably enhance the illustrative capability of
choropleth maps in public health and epidemiology.
The paper is organised as follows. Basic ideas, statisti-
cal methods, and the combined approach are presented
before the combined approach is applied to two data
sets. A discussion and conclusions section closes the
paper.
Methods
The main features of difference and equivalence tests
are motivated with the one-sample t-test. Based on it,
the combination of both test principles is thoroughly
ventilated. Although these considerations are general by
nature, the application of permutation tests may pose
additional questions which are considered and exempli-
fied with standard mortality ratios (SMR’s). Multiple
testing and a Bayesian alternative approach are briefly
considered as well. * Correspondence: harald.heinzl@meduniwien.ac.at
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Consider a single group with normally distributed out-
comes, X ~N ( μ,s
2), where μ and s
2 are the unknown
population mean and variance. The research question
whether the population mean differs from a chosen con-
stant c is usually answered with a one-sample t-test of
the null hypothesis H0: μ = c on a prespecified signifi-
cance level a. The corresponding non-directional two-
sided alternative hypothesis is denoted by HA: μ ≠ c.
The null hypothesis H0: μ = c can be considered as
intersection of two one-sided null hypotheses H01: μ ≤ c
and H02: μ ≥ c, respectively. Testing them can be under-
stood as a closed testing procedure which holds the
multiple level a and a confirmatory directional conclu-
sion is possible (see e.g. [1], [2]). The corresponding
one-sided directional alternatives are HA1: μ >c and HA2:
μ <c, respectively.
In the case of one-sample t-test the application of a
two-sided level a test comprises the computation of a
realisation t of a test statistic T, and its comparison with
some lower and upper critical values critlow and critupp,
respectively. If t ∉ [critlow,critupp], then H0 will be
rejected for the non-directional hypothesis testing
approach; if t >critupp or t <critlow ,t h e nH 01 or H02 will
be rejected for the directional approach, respectively.
T h eu s eo fat w o - s i d e d( 1-a) -confidence interval
provides an alternative way to perform a two-sided level
a difference test. Let xx low upp ,/ , / ,  21 2 − ⎡ ⎣ ⎤ ⎦ denote the
common symmetric (1 - a) -confidence interval for μ.I f
cx x low upp ∉ ⎡ ⎣ ⎤ ⎦ − ,, ,  21 2 ,t h e nH 0 will be rejected for
the non-directional hypothesis testing approach. If
xc low, 2 > or xc upp,1 2 − <  ,t h e nH 01 or H02 will be
rejected for the directional approach, respectively. Three
crucial confidence interval scenarios as results of a dif-
ference test are depicted in Figure 1. Note that, even if
not intended, confidence intervals always provide direc-
tional information as well.
The one-sample t-test as equivalence test
A not significant difference test cannot be interpreted as
acceptance of the null hypothesis. The population mean
μ is only considered equivalent to a chosen constant c if
they do not differ too much, that is, if μ Î (c - Δ1, c +
Δ2). The acceptable differences Δ1and Δ2 re called
equivalence margins and have to be predetermined.
Often, Δ1=Δ2 will be chosen for a normally distributed
outcome. The equivalence limits c - Δ1 and c +Δ2form
the equivalence range.
Statistical equivalence testing is commonly based on a
two one-sided tests (TOST) approach. If both one-sided
null hypotheses ΗΔ 01 1
∗ ≤− :  c and ΗΔ 02 2
∗ ≥+ :  c
are rejected at a significance level a each, then the
population mean μ can be declared equivalent to c.
The TOST approach can be easily performed by
employing a confidence interval. Equivalence will be
attained, if the two-sided (1 - 2a)-confidence interval
xx low upp ,, ,  1− ⎡ ⎣ ⎤ ⎦ is completely covered by the equiva-
lence range (c - Δ1,c + Δ2), that is, if cx low −< Δ1,  and
cx upp +> − Δ21 ,  .
If the equivalence limits c - Δ1 and c + Δ2 together
with the null hypothesis value c are considered, then ten
different equivalence test outcome scenarios can be
identified combinatorially (Figure 2). Equivalence would
be obtained with scenarios E3, E6 and E8,a l lo t h e rs c e -
narios would be declared not equivalent.
Combining difference and equivalence tests
If both a difference and an equivalence test are per-
formed on the same sample, then the corresponding
(1 - a)-confidence interval of the difference test will
cover the (1 - 2a)-confidence interval of the equivalence
test. Consequently, provided we have observed a statisti-
cally significantly different result, either D-1 or D+1 (Fig-
ure 1), then in each case three equivalence scenarios, E1
- E3 or E8 - E10, are possible, respectively (Figure 2).
If no significantly different result has been observed (D0,
Figure 1), then any of the ten equivalence scenarios will
be conceivable.
This has interesting consequences. If the equivalence
interval contains the value c which is the case for E4 -
E7, then the corresponding difference test will show a
statistically not significant result. If, however, the
equivalence interval does not contain c which is the case
for E1 - E3 and E8 - E10, then the result of the difference
test will not be immediately evident inasmuch as the dif-
ference test confidence interval is at least as wide as its
equivalence counterpart.
Admittedly, the scenarios E1 | D0 and E10 | D0 seem
implausible, however, they cannot be logically ruled out.
Consider, e.g., the combination E1 | D0 which is equiva-
lent to xc upp,1 1 − <−  Δ and xc upp,1 2 − >  .T h e s ec o n -
ditions will only apply, if Δ1 and the sample size are
sufficiently small and the standard deviation is suffi-
ciently large, respectively.
The combined representation of difference and
equivalence test results would have to consider 16 com-
bined scenarios which, however, is a confusing and
unfeasible maximal variant. Practically more applicable
seems the reduction of the possible equivalence test
results to “equivalent” and “not equivalent” which, in
combination with the corresponding difference test
results, eventually leads to six combined scenarios
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gory irrespectively of the difference test result the number
of these combinations is reduced to four (Table 1). The
category “not equivalent and not significantly different” is
a rather uninformative residual category, whereas the
other five or three categories contain precise information,
respectively.
Difference and equivalence testing with SMR’s
We have motivated difference and equivalence testing
with the one-sample t-tests, however, the underlying
principle applies to any type of outcome data. E.g., if
standardised mortality ratios (SMR’s) are considered,
then the null hypothesis value c will usually be set to
one, c = 1, and the equivalence limits will be frequently
determined by 1 - Δ1 =1 / ( 1+Δ2). A traditional choice
in bioequivalence trials will be Δ1 = 0.2 [3], which leads
to an equivalence range of (0.8, 1.25). Its asymmetry is
typical for proportional measurement scales like ratios.
Inferential statistics for SMR’s is usually based on the
Poisson distribution. In the case of a discrete distribu-
tion of the test statistic (e.g. Poisson, Binomial, etc.) the
computation of p-values and confidence intervals can be
performed with the so-called twice-the-smaller-tail
(TST) method ([4], p. 59). That is, the two-sided test
results at level a are derived from a combination of the
two corresponding one-sided results at level a/2 each
([4], p. 60). Obviously, equivalence testing by TOST is
TST per definition. However, the TST method can
become rather conservative [4].
Our method requires that a (1 - a)-confidence interval
covers its corresponding (1 - 2a)-confidence interval.
This so-called property of nestedness [4] seems to be
naturally met in general, however, it is not guaranteed
in the field of discrete data and permutation tests, when
different confidence interval construction principles are
applied. That is, a non-TST (1 - a)-confidence interval
of the difference test does not necessarily cover the TST
(1 - 2a)-confidence interval of the corresponding
equivalence test [4]. The property of nestedness may
also become an issue if the conservativeness of the TST
method is reduced by employing the so-called mid-p
correction [4].
Multiple testing
Jointly performing a difference and an equivalence test
for a single spatial unit maintains the multiple level of
significance at a [for a proof see Additional file 1].
Performing such combined tests for a multitude of
spatial units inevitably increases the risk for type I and
type III (directional) errors. Adjustments for multiple
testing can be applied as long as the property of
Figure 1 Schematic representation of possible difference test results depicted with (1-a) confidence intervals. D-1, D0 and D+1 show a
significantly smaller, a not significant and a significantly larger test result, respectively.
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Page 3 of 10Figure 2 Schematic representation of possible equivalence test results depicted with (1-2a) confidence intervals. Scenarios E3, E6 and E8
show equivalence to a chosen constant c, whereas all other scenarios show non-equivalence. Note that a (1-2a) equivalence test confidence
interval is by definition covered by its corresponding (1-a) difference test confidence interval.
Table 1 Two schemes to distinguish mutual difference and equivalence test results in choropleth maps
Equivalence test
result
Difference test
result
Six combined scenarios Four combined scenarios
E3 D-1 equivalent and significantly smaller equivalent (that is, result of difference test does not
matter)
E3, E6, E8 D0 equivalent and not significantly different
E8 D+1 equivalent and significantly larger
E1, E2 D-1 not equivalent and significantly smaller not equivalent and significantly smaller
E1, E2, E4, E5, E7, E9, E10 D0 not equivalent and not significantly
different
not equivalent and not significantly different
E9, E10 D+1 not equivalent and significantly larger not equivalent and significantly larger
Note: The first scheme (column “6 combined scenarios”) combines the three difference test results with the two main results of the equivalence test. The second
scheme (column “4 combined scenarios”) is a simplified alternative to the former. All significantly equivalent results are considered as one category, irrespectively
of the result of the difference test. The difference test result only matters then in the case of a not equivalent result.
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tiplicity-adjusted confidence interval of a difference test
still covers the multiplicity-adjusted confidence interval
of the corresponding equivalence test.
The Bayesian approach
Wellek [5] notices that in situations, where Bayesian
credible intervals coincide with classical confidence
intervals, a Bayesian equivalence testing procedure in
analogy to the classical TOST approach can be applied.
We propose - analogous to the described classical
approach - to combine (1 - a)- and (1 - 2a)-credibility
intervals to a sort of combined Bayesian difference and
equivalence testing approach.
The specified prior distribution and the observed data
are used to determine the posterior distribution of the
parameter of interest, which is considered a random
variable then. A Bayesian difference test can now be
derived from the posterior probability that the para-
meter of interest exceeds the value c.T h ep o s t e r i o r
probability that the parameter lies within the equiva-
lence range (c - Δ1,c + Δ2) provides the basis of Bayesian
equivalence decision-making.
Results
The following two examples are based on Austrian vital
statistics data (source: Statistics Austria [6]) which
includes all births in Austria from 1970 onwards. The
Republic of Austria consists of 121 administrative dis-
tricts, from which 23 (19%) constitute the densely popu-
lated capital city Vienna. About 1.7 million (20%) out of
about 8.4 million inhabitants live in Vienna. For the
sake of better visualisation we have cut out Vienna in
our choropleth maps from its location in the north-east
of Austria, magnified it and placed it above the western
districts (Figures 3, 4 and 5). The choropleth maps have
been produced with ArcGIS 9. A significance level a =
0.05, as is customary in medicine, was used throughout
the examples.
Gestational age in Austria 2008
In 2008, a total of 60,303 newborns with Austrian
mothers had been recorded from where we analysed
gestational age within the administrative districts. Tests
for equivalence and difference were done in SAS using
the procedure TTEST (option TOST for equivalence
test). The equivalence range (c - Δ1,c + Δ2)w a ss e tt oa
width of 4 days, i.e. Δ1 = Δ2 =2 / 7=0 . 2 8 6w e e k sa n dc
was set to the sample mean x of Austrian newborns
recorded from 1999 to 2007, that is, cx == 39 4 .1 7
weeks.
The mean gestational ages of the districts are split at
the quartiles into four categories which are represented
with different colours. Six combined scenarios of the
equivalence/difference test results are represented with
different symbols (Table 1). Both, colours and symbols
are displayed together in one graphic (Figure 3).
The non-random spatial distribution of mean gesta-
tional ages is obvious (Figure 3). In particular, shorter
gestational age seems to be common in the south-eastern
parts of Austria. Prolonged gestational age becomes more
frequent in the north-eastern, central and western parts
of Austria. The equivalence/difference testing informa-
tion supports this impression (Figure 3). There is an
equivalence/difference testing symbol in the opening
which appeared after cutting out the capital Vienna. It
belongs to a district surrounding Vienna which consists
of several spatially separated areas.
Jointly displaying the variable of interest with colours
and the equivalence/difference test results with symbols
clearly emphasizes the former over the latter. Detailed
information for specific districts can be retained on clo-
ser inspection, but it is rather difficult to get an overall
spatial impression of the equivalence/difference testing
information from this form of graphical representation.
Infant mortality in Austria 1984-2007
Infant mortality (death of a live birth during the first
year) was recorded between 1984 and 2007 in 121
administrative districts. A total of 10,914 out of
1,985,203 live births deceased. Inclusion criteria for the
data set were that the infants had been born as single-
tons between the 24th and 44th week of gestation to
mothers between 13 to 50 years of age. Expected num-
bers of cases per district were calculated by multiplying
the national infant mortality rate with district specific
numbers of births. Standardized mortality ratios were
calculated as in Waldhoer et al. [7]. Equivalence and dif-
ference tests were performed with the SAS macro of
Daly [8]. The equivalence range (0.8, 1.25) was used.
The district SMR’s are split at the quartiles into four cate-
gories and represented with different colours (Figure 4).
Four combined scenarios of the equivalence/difference test
results are as well represented with different colours in a
s e p a r a t eg r a p h i c( T a b l e1 ,F i g u r e5 ) .
The results of the combined equivalence/difference
test results in Figure 5 only partly confirm the results of
Figure 4 as more than half of the districts do not allow
conclusive decisions.
Separately representing the variable of interest and the
equivalence/difference test results with colours puts
equal emphasis on both features which is in contrast to
the colours/symbols representation of Figure 3.
Discussion and conclusions
The two examples (Figure 3 and Figures 4-5) are proto-
typic for the two different main motivations of
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Page 5 of 10integrating difference and equivalence test results into
choropleth maps. The main aim of Figure 3 is a concise
combination of the spatial distribution of the variable of
interest and the statistical test results, where the focus is
on the former and the latter is meant to provide supple-
mentary information only. On the other hand, Figures 4
and 5 show a situation where both, data description and
statistical testing are of equal interest. It should be
noted that other forms of graphical representation could
be considered to effectively communicate the bivariate
information [see e.g. [9-11]].
The non-random spatial distribution of infant mortal-
ity in Figure 4 closely resembles that of gestational age
in Figure 3. Shorter gestational age seems to be
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Legend
mean gestational age per district
38.4 - 39.2 weeks
39.2 - 39.4 weeks
39.4 - 39.5 weeks
39.5 - 40.5 weeks
combined test results
ť equivalent and significantly smaller
ő equivalent and not significantly different
Ũ equivalent and significantly larger
< not equivalent and significantly smaller
ż not equivalent and not significantly different
<
not equivalent and significantly larger
m
m
m
m
Figure 3 Gestational age in Austria 2008. Different colours refer to different mean gestational ages (in weeks), different symbols refer to
different results of a difference/equivalence test combination ("6 combined scenarios”).
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Page 6 of 10associated with decreased infant mortality. Drawing cau-
sal relationships, however, may be fallacious for two rea-
sons. Firstly, the study times do not overlap (2008 in
Figure 3 and 1984-2007 in Figure 4), and secondly,
there is the possibility of an ecological inference fallacy.
Figure 4 provides a rather typical example of a tradi-
tional epidemiological choropleth map. The clear non-
random spatial distribution in Figure 4 exhibits many
districts with increased and decreased risk in the north-
west and south-east of Austria, respectively. When
defining a range from 0.8 to 1.25 as equivalent and
therefore not important enough to raise public health
concerns, then about 40% of the districts will allow
conclusive decisions (red-, green- and blue-coloured
districts in Figure 5). The indefiniteness of the gray-
coloured districts may be mainly due to lack of statisti-
cal power, however, in any case valuable additional
information for local health authorities is provided.
Both examples differ in a further small, but crucial
detail. In the gestational age example, the null hypoth-
esis value c is determined from a previous data set
(1999 to 2007) in order to test the various districts in
Legend
SMR per district
0.648 - 0.901
0.902 - 0.997
0.998 - 1.081
1.082 - 1.321
Figure 4 SMR’s of infant mortality in Austria 1984-2007. Different colours refer to different SMR’s.
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Page 7 of 10the data set at hand (2008), and both data sets do not
overlap.
In the infant mortality example, on the contrary, all
live births from 1984 to 2007 were used to calculate the
national infant mortality rate which, via SMR, is tested
against the district infant mortality rates from 1984 to
2007. That is, the null hypothesis is partially determined
b yt h ed a t aw h i c ha r et ob et e s t e d .T h i sm e a n st h a ta
districts rate is compared with all other district rates
including its own one. Although such an approach is
statistically questionable, it is quite common in spatial
epidemiology. As long as the number of cases and the
size of the population of the respective district are small
compared to the whole national sample, the thereby
arising bias can be safely ignored. Note that there is a
structurally similar problem in the field of relative survi-
val where people suffering from an illness are compared
to the overall population including the diseased ones.
Both examples are based on fixed effect estimators,
which neither do account for spatial autocorrelation in
the underlying variables nor do correct for the inherent
multiplicity. It would be rather straightforward to
Legend
combined test results
equivalent (ignore difference test result)
not equivalent and significantly smaller
not equivalent and not significantly different
not equivalent and significantly larger
Figure 5 Difference/equivalence test results for infant mortality in Austria 1984-2007. Different colours refer to different results of a
difference/equivalence test combination ("4 combined scenarios”).
Waldhoer and Heinzl International Journal of Health Geographics 2011, 10:3
http://www.ij-healthgeographics.com/content/10/1/3
Page 8 of 10translate the approach to random or mixed effect mod-
els with either global or local shrinkage (spatial smooth-
ing) which “borrow strength” from adjacent districts.
Corrections for multiple testing could be performed
within the models in order to account for reduced
degrees of freedom by positive spatial autocorrelation.
Multiple testing will not be an explicit issue if spatial
smoothing is performed within a Bayesian setting as “a
correct adjustment is automatic within the Bayesian
paradigm” [12].
Note that the decision for a multiplicity adjustment
before reporting public health results has to consider
both technical and non-technical points. Multiplicity
i sa ni s s u et ob ek e p ti nm i n dw h e nl o o k i n gf r o ma
nationwide or transregional level at a series of regio-
nal test results. On the contrary, individual persons
and local health authorities may only be interested in
their corresponding local area results. Similar argu-
ments apply for the choice between simple fixed effect
and spatially smoothed estimates. There might be
local health authorities, who might resist against a
seeming degradation of their spotless public health
records by the inclusion of ill-performing neighboring
districts due to spatial smoothing. Critics from the
local residents and the media might argue that shrink-
age and smoothing is merely a convenient tool for
understating unpleasant results, particularly, as spatial
smoothing may yield essentially conservative results
[13]. On the other hand, spatially smoothed results
a r em o r es t a b l ea n dl e s sp r o n et or a n d o mf l u c t u a t i o n s .
Governmental agencies interested in an overall picture
may favor them.
Concluding, we think that enhancing spatial maps with
a combination of statistical difference and equivalence
test results could help to classify epidemiological findings
the right way. A better understanding of spatial observa-
tions could be achieved by explicitly defining their rele-
vance through a pre-defined equivalence range. In order
to apply our suggested method all is needed are confi-
dence intervals or - in a Bayesian setting - credibility
intervals for the small area parameters of interests. Tech-
nically, it does not matter whether or not these intervals
have been “preprocessed” by multiplicity adjustments or
spatial smoothing.
Finally note that equivalence and difference may have
other sensible meanings than those employed here. In
the field of spatial epidemiology equivalence may be
considered as spatial clustering and difference may be
related to spatial outliers or excessive observations.
Examples of methods which address these notions of
equivalence and difference in combination include LISA
statistics [14] and Oden’s Ipop [15].
Additional material
Additional file 1: Does the joint application of a difference and an
equivalence test pose a multiple testing problem? It is stated in the
Multiple testing subsection that jointly performing a difference and an
equivalence test for a single spatial unit maintains the multiple level of
significance at a. A formal proof for this statement is provided.
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